INVITED INTERNATIONAL SPEAKERS
Prof Jeanine Roeters van Lennep has been working as an internist specializing in vascular medicine at the Erasmus Medical Center, Rotterdam, the Netherlands since 2010. She is head of the vascular medicine clinic specialized in hereditary dyslipidemia. She combines this research interest with gender-specific medicine. Her scientific research is dedicated to cardiovascular prevention, specifically diagnosis and treatment of Familial Hypercholesterolemia and sex-specific cardiovascular risk factors such as pre-eclampsia for which she obtained grants of e.g. the Dutch Heart Foundation and the Dutch Research Council.
She is very eager to share her enthusiasm on sex- and gender-specific medicine by organizing educational activities such as the 3-day Gender & Health Course and mentoring junior doctors and researchers.
Jeanine has broad leadership experience as board member of various scientific societies. Currently she is chair of the Dutch Society of Vascular Medicine, chair of the HORIZONSCAN committee of the Dutch National Healthcare Institute to review upcoming cardiovascular drugs, and board member of the Dutch Society of Gender & Health. Moreover she has been chair of the first Dutch Guideline on Dyslipidemia.
She is also involved in the Scandinavian Society of Atherosclerosis Research, an official EAS National Society, for which she organized invited speakers as chairperson in several editions and currently holds the post as financial auditor.
Jeanine is an active member of the EAS. Besides having attended and actively participated in many EAS congresses in the past years, she also organized the very successful Pediatric Familial Hypercholesterolemia Symposium as an official satellite symposium of the 87th EAS congress in 2019.
INVITED NATIONAL SPEAKERS
Associate Professor Christina Bursill (BSc (Hons 1) PhD, Adelaide University; Postdoc, Oxford University, UK) is a leader in cardiovascular biology for her expertise in the biology and mechanisms of atherosclerotic plaques and mechanisms of angiogenesis. She is Co-director of the Vascular Research Centre at the South Australian Health and Medical Research Institute (SAHMRI) and the University of Adelaide and is a 2x National Heart Foundation (NHF) Fellow. As CIA she has received >$4.5 million in competitive national research funding in the last 4 years. A/Prof Bursill has published >110 manuscripts, supervised >18 PhD students to completion and currently leads a research team of ten people. A/Prof Bursill co-Chairs the South Australian Cardiovascular Research network, is a Board member of the International Atherosclerosis Society, has held a board position (Treasurer) for the Australian Cardiovascular Alliance (ACvA) and is the past-President of the Australian Atherosclerosis Society.
Professor Stephen Nicholls (MBBS (Hons), PhD, FRACP, FCSANZ, FESC) is Director of the Victorian Heart Hospital, Professor of Cardiology and Director of the Victorian Heart Institute at Monash University. He is a preventive cardiologist with translational research interests that focus on developing innovative approaches to preventing and treating heart disease. His career has included clinical training in Adelaide and Newcastle, doctoral studies at the University of Adelaide and postdoctoral and faculty appointments at the Cleveland Clinic. He returned to Australia to take up the role of Deputy Director and Heart Health theme leader at the South Australian Health and Medical Research Institute. He moved to Monash University to build and open Australia’s first stand-alone institution dedicated to clinical care, research and teaching of cardiovascular disease. His research interests span from bench to bedside, focusing on mechanisms of atherosclerotic disease, plaque imaging and leadership of clinical trials of novel cardioprotective therapies. He is Past President of the Cardiac Society of Australia and New Zealand and the Australian Atherosclerosis Society, lead investigator of the Australian Stroke and Heart Research Accelerator and is an inaugural Fellow of the Australian Academy of Health and Medical Sciences. His research productivity includes raising more than $190M in research funding, 1300 manuscripts, book chapters and conference proceedings, 3 patents and awards for research excellence from the Cardiac Society of Australia and New Zealand, Royal Australasian College of Physicians and European Atherosclerosis Society and has been recognised by Clarivate as one of the World’s Most Influential Researchers in Clinical Medicine. He is currently completing construction of the Velos Research Accelerator, dedicated to delivering research innovations in cardio-kidney-metabolic disease to the clinic and community.